标题
Strategies for the Treatment of Parkinson’s Disease: Beyond Dopamine
作者
关键词
-
出版物
Frontiers in Aging Neuroscience
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-01-31
DOI
10.3389/fnagi.2020.00004
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- α-Synuclein and astrocytes: tracing the pathways from homeostasis to neurodegeneration in Lewy body disease
- (2019) Zachary A. Sorrentino et al. ACTA NEUROPATHOLOGICA
- Non‐viral nucleic acid delivery to the central nervous system and brain tumors
- (2019) Shanshan Wang et al. JOURNAL OF GENE MEDICINE
- CLINICAL TRIAL HIGHLIGHTS: 1. GENE THERAPY FOR PARKINSON’S, 2. PHASE 3 STUDY IN FOCUS - INTEC PHARMA’S ACCORDION PILL, 3. CLINICAL TRIALS RESOURCES
- (2019) Kevin McFarthing et al. Journal of Parkinsons Disease
- Clinical translation of gene medicine
- (2019) Fazhan Wang et al. JOURNAL OF GENE MEDICINE
- Contribution of cholinergic interneurons to striatal pathophysiology in Parkinson's disease
- (2019) Samira Ztaou et al. NEUROCHEMISTRY INTERNATIONAL
- Generation of a caged lentiviral vector through an unnatural amino acid for photo-switchable transduction
- (2019) Yan Wang et al. NUCLEIC ACIDS RESEARCH
- Human gene therapy approaches for the treatment of Parkinson's disease: An overview of current and completed clinical trials
- (2019) Frederick L. Hitti et al. PARKINSONISM & RELATED DISORDERS
- Development of hRad51–Cas9 nickase fusions that mediate HDR without double-stranded breaks
- (2019) Holly A. Rees et al. Nature Communications
- Surveillance and transportation of mitochondria in neurons
- (2019) Roeland Vanhauwaert et al. CURRENT OPINION IN NEUROBIOLOGY
- Targeting microglia with lentivirus and AAV: Recent advances and remaining challenges
- (2019) Margaret E. Maes et al. NEUROSCIENCE LETTERS
- Developing a Versatile Shotgun Cloning Strategy for Single-Vector-Based Multiplex Expression of Short Interfering RNAs (siRNAs) in Mammalian Cells
- (2019) Xi Wang et al. ACS Synthetic Biology
- Search-and-replace genome editing without double-strand breaks or donor DNA
- (2019) Andrew V. Anzalone et al. NATURE
- CRISPR System: A High-throughput Toolbox for Research and Treatment of Parkinson’s Disease
- (2019) Fatemeh Safari et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Integration of the human exposome with the human genome to advance medicine
- (2018) R. Barouki et al. BIOCHIMIE
- Candidate biomarkers for Parkinson's disease
- (2018) Ali Khodadadian et al. BIOMEDICINE & PHARMACOTHERAPY
- Long-term Outcome of Adenosine A2A Receptor Antagonist on Lower Urinary Tract Symptoms in Male Parkinson Disease Patients
- (2018) Takeya Kitta et al. CLINICAL NEUROPHARMACOLOGY
- Delivering CRISPR: a review of the challenges and approaches
- (2018) Christopher A. Lino et al. DRUG DELIVERY
- Primary tissue for cellular brain repair in Parkinson's disease: Promise, problems and the potential of biomaterials
- (2018) Niamh Moriarty et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Intranasal Cotinine Plus Krill Oil Facilitates Fear Extinction, Decreases Depressive-Like Behavior, and Increases Hippocampal Calcineurin A Levels in Mice
- (2018) Nathalie Alvarez-Ricartes et al. MOLECULAR NEUROBIOLOGY
- (E)-Nicotinaldehyde O-Cinnamyloxime, a Nicotine Analog, Attenuates Neuronal Cells Death Against Rotenone-Induced Neurotoxicity
- (2018) Juan Camilo Jurado-Coronel et al. MOLECULAR NEUROBIOLOGY
- International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease
- (2018) Susan H. Fox et al. MOVEMENT DISORDERS
- p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells
- (2018) Robert J. Ihry et al. NATURE MEDICINE
- Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson’s disease
- (2018) Emily M. Rocha et al. NEUROBIOLOGY OF DISEASE
- Ventral midbrain astrocytes display unique physiological features and sensitivity to dopamine D2 receptor signaling
- (2018) Wendy Xin et al. NEUROPSYCHOPHARMACOLOGY
- α-Synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies
- (2018) Iryna Prots et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Gene Therapy for Parkinson’s Disease, An Update
- (2018) Tobias M. Axelsen et al. Journal of Parkinsons Disease
- Is There Evidence for a Rostral-Caudal Gradient in Fronto-Striatal Loops and What Role Does Dopamine Play?
- (2018) David A. Vogelsang et al. Frontiers in Neuroscience
- Linking Glycation and Glycosylation With Inflammation and Mitochondrial Dysfunction in Parkinson’s Disease
- (2018) Paula A. Q. Videira et al. Frontiers in Neuroscience
- Emerging and alternative therapies for Parkinson disease: an updated review
- (2018) Atul Kabra et al. CURRENT PHARMACEUTICAL DESIGN
- Cotinine Reduces Amyloid-β Aggregation and Improves Memory in Alzheimer's Disease Mice
- (2018) Valentina Echeverria et al. JOURNAL OF ALZHEIMERS DISEASE
- Gene therapy for neurological disorders: progress and prospects
- (2018) Benjamin E. Deverman et al. NATURE REVIEWS DRUG DISCOVERY
- Expression of α-synuclein is regulated in a neuronal cell type-dependent manner
- (2018) Katsutoshi Taguchi et al. ANATOMICAL SCIENCE INTERNATIONAL
- Nicotine protects against manganese and iron-induced toxicity in SH-SY5Y cells: Implication for Parkinson's disease
- (2018) Bruk Getachew et al. NEUROCHEMISTRY INTERNATIONAL
- Striatal cholinergic interneurons and Parkinson's disease
- (2017) Asami Tanimura et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Stem Cells for Modeling and Therapy of Parkinson's Disease
- (2017) Qingxi Zhang et al. HUMAN GENE THERAPY
- Clinical Gene Therapy for Neurodegenerative Diseases: Past, Present, and Future
- (2017) Françoise Piguet et al. HUMAN GENE THERAPY
- CRISPR-Cas9 Mediated Telomere Removal Leads to Mitochondrial Stress and Protein Aggregation
- (2017) Hyojung Kim et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Management of Parkinson Disease in 2017
- (2017) Michael S. Okun JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The changing landscape of surgery for Parkinson's Disease
- (2017) Christopher S. Lozano et al. MOVEMENT DISORDERS
- Cognitive decline in Parkinson disease
- (2017) Dag Aarsland et al. Nature Reviews Neurology
- Non-motor features of Parkinson disease
- (2017) Anthony H. V. Schapira et al. NATURE REVIEWS NEUROSCIENCE
- Neural grafting for Parkinson's disease: challenges and prospects
- (2017) ThomasB Stoker et al. Neural Regeneration Research
- Caffeine as symptomatic treatment for Parkinson disease (Café-PD)
- (2017) Ronald B. Postuma et al. NEUROLOGY
- Cotinine improves visual recognition memory and decreases cortical Tau phosphorylation in the Tg6799 mice
- (2017) J. Alex Grizzell et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease
- (2017) Lena F. Burbulla et al. SCIENCE
- Cell Biology and Pathophysiology of α-Synuclein
- (2017) Jacqueline Burré et al. Cold Spring Harbor Perspectives in Medicine
- Mesenchymal Stem Cells as a Source of Dopaminergic Neurons: A Potential Cell Based Therapy for Parkinson's Disease
- (2017) Katari Venkatesh et al. Current Stem Cell Research & Therapy
- Replacing Dopamine Neurons in Parkinson’s Disease: How did it happen?
- (2017) Anders Björklund et al. Journal of Parkinsons Disease
- MicroRNAs in Parkinson’s disease
- (2017) Abhishek Singh et al. EXPERIMENTAL BRAIN RESEARCH
- Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations
- (2017) Anthony H. V. Schapira et al. JAMA Neurology
- Synucleins and Gene Expression: Ramblers in a Crowd or Cops Regulating Traffic?
- (2017) Alexei A. Surguchev et al. Frontiers in Molecular Neuroscience
- RNA Interference of Human α-Synuclein in Mouse
- (2017) Young-Cho Kim et al. Frontiers in Neurology
- Imaging biomarkers in Parkinson’s disease and Parkinsonian syndromes: current and emerging concepts
- (2017) Usman Saeed et al. Translational Neurodegeneration
- Worsening of Verbal Fluency After Deep Brain Stimulation in Parkinson's Disease: A Focused Review
- (2017) Andreas Højlund et al. Computational and Structural Biotechnology Journal
- Alpha-Synuclein as a Biomarker for Parkinson's Disease
- (2016) Anzari Atik et al. BRAIN PATHOLOGY
- Repression of the Antioxidant NRF2 Pathway in Premature Aging
- (2016) Nard Kubben et al. CELL
- Induced pluripotent stem cells and Parkinson's disease: modelling and treatment
- (2016) Xiaoyun Xu et al. CELL PROLIFERATION
- Implication of Green Tea as a Possible Therapeutic Approach for Parkinson Disease
- (2016) Juan C. Jurado-Coronel et al. CNS & Neurological Disorders-Drug Targets
- Targeting the Nicotinic Acetylcholine Receptors (nAChRs) in Astrocytes as a Potential Therapeutic Target in Parkinson's Disease
- (2016) Juan Camilo Jurado-Coronel et al. CURRENT PHARMACEUTICAL DESIGN
- Molecular basis of reactive oxygen species-induced inactivation of α4β2 nicotinic acetylcholine receptors
- (2016) Junjun Zhao et al. FREE RADICAL BIOLOGY AND MEDICINE
- Mitochondrial dysfunction in Parkinson's disease
- (2016) Anindita Bose et al. JOURNAL OF NEUROCHEMISTRY
- Cognitive impairment in Parkinson's disease and dementia with Lewy bodies
- (2016) Dag Aarsland PARKINSONISM & RELATED DISORDERS
- Are Stem Cell-Based Therapies for Parkinson’s Disease Ready for the Clinic in 2016?
- (2016) Roger A. Barker et al. Journal of Parkinsons Disease
- Time Trends in the Incidence of Parkinson Disease
- (2016) Rodolfo Savica et al. JAMA Neurology
- Improvement of dyskinesias withl-dopa infusion in advanced Parkinson's disease
- (2015) J. Timpka et al. ACTA NEUROLOGICA SCANDINAVICA
- Alpha-synuclein (SNCA) polymorphisms and susceptibility to Parkinson's disease: A meta-analysis
- (2015) Wei Han et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Mitochondrial dysfunction in aging: Much progress but many unresolved questions
- (2015) Brendan A.I. Payne et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Neuroprotective Properties of the Standardized Extract fromCamellia sinensis(Green Tea) and Its Main Bioactive Components, Epicatechin and Epigallocatechin Gallate, in the 6-OHDA Model of Parkinson’s Disease
- (2015) Natália Bitu Pinto et al. Evidence-based Complementary and Alternative Medicine
- Istradefylline is Recommended for Morning Use: A Report of 4 Cases
- (2015) Keita Matsuura et al. INTERNAL MEDICINE
- Mutations in the glucocerebrosidase gene are common in patients with Parkinson's disease from Eastern Canada
- (2015) Fabin Han et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- 1α,25-Dihydroxyvitamin D3Regulates Mitochondrial Oxygen Consumption and Dynamics in Human Skeletal Muscle Cells
- (2015) Zachary C. Ryan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson’s disease model
- (2015) Alevtina D. Zharikov et al. JOURNAL OF CLINICAL INVESTIGATION
- Evidence for limited D1 and D2 receptor coexpression and colocalization within the dorsal striatum of the neonatal mouse
- (2015) Dominik K. Biezonski et al. JOURNAL OF COMPARATIVE NEUROLOGY
- Clinical translation of stem cell transplantation in Parkinson's disease
- (2015) O. Lindvall JOURNAL OF INTERNAL MEDICINE
- Distinct Midbrain and Habenula Pathways Are Involved in Processing Aversive Events in Humans
- (2015) K. Hennigan et al. JOURNAL OF NEUROSCIENCE
- Evidence against dopamine D1/D2 receptor heteromers
- (2015) A L Frederick et al. MOLECULAR PSYCHIATRY
- Striatal cholinergic interneurons and cortico-striatal synaptic plasticity in health and disease
- (2015) Marc Deffains et al. MOVEMENT DISORDERS
- Deep-brain stimulation associates with improved microvascular integrity in the subthalamic nucleus in Parkinson's disease
- (2015) Ilse S. Pienaar et al. NEUROBIOLOGY OF DISEASE
- Regulation of c-fos expression by the dopamine D1-D2 receptor heteromer
- (2015) M.L. Perreault et al. NEUROSCIENCE
- The Parkinson Disease Mitochondrial Hypothesis
- (2015) Sandra Franco-Iborra et al. NEUROSCIENTIST
- Pharmacokinetics of cotinine in rats: A potential therapeutic agent for disorders of cognitive function
- (2015) Pei Li et al. Pharmacological Reports
- Treatment of Parkinson's disease using cell transplantation
- (2015) Olle Lindvall PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease
- (2015) Brent J. Ryan et al. TRENDS IN BIOCHEMICAL SCIENCES
- Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson’s disease
- (2015) George E. Barreto et al. Frontiers in Aging Neuroscience
- Dopamine Receptors and Neurodegeneration
- (2015) Claudia Rangel-Barajas et al. Aging and Disease
- Mitochondrial Dysfunction in Parkinson's Disease
- (2015) Hyo Eun Moon et al. Experimental Neurobiology
- Cotinine reduces depressive-like behavior and hippocampal vascular endothelial growth factor downregulation after forced swim stress in mice.
- (2014) J. Alex Grizzell et al. BEHAVIORAL NEUROSCIENCE
- Cotinine reduces depressive-like behavior, working memory deficits, and synaptic loss associated with chronic stress in mice
- (2014) J. Alex Grizzell et al. BEHAVIOURAL BRAIN RESEARCH
- Evaluation of nicotine and cotinine analogs as potential neuroprotective agents for Alzheimer’s disease
- (2014) Jie Gao et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Endometrial stem cell transplantation in MPTP- exposed primates: an alternative cell source for treatment of Parkinson's disease
- (2014) Erin F. Wolff et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Postoperative delirium in Parkinson’s disease patients following deep brain stimulation surgery
- (2014) Jonathan D. Carlson et al. JOURNAL OF CLINICAL NEUROSCIENCE
- The Parkinsonian mimetic, 6-OHDA, impairs axonal transport in dopaminergic axons
- (2014) Xi Lu et al. Molecular Neurodegeneration
- Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr
- (2014) Andrew J. Lees et al. MOVEMENT DISORDERS
- Neurodegenerative disease: Brain windfall
- (2014) Katharine Gammon NATURE
- Direct and indirect pathways of basal ganglia: a critical reappraisal
- (2014) Paolo Calabresi et al. NATURE NEUROSCIENCE
- Implementing personalized cancer care
- (2014) Richard L. Schilsky Nature Reviews Clinical Oncology
- New Insights into the Mechanisms of Action of Cotinine and its Distinctive Effects from Nicotine
- (2014) J. Alex Grizzell et al. NEUROCHEMICAL RESEARCH
- Multisensory Integration in the Mouse Striatum
- (2014) Ramon Reig et al. NEURON
- Striatal Cholinergic Interneurons Drive GABA Release from Dopamine Terminals
- (2014) Alexandra B. Nelson et al. NEURON
- Cotinine halts the advance of Alzheimer's disease-like pathology and associated depressive-like behavior in Tg6799 mice
- (2014) Sagar Patel et al. Frontiers in Aging Neuroscience
- Nicotinic Acetylcholine Receptor Density in Cognitively Intact Subjects at an Early Stage of Parkinson’s Disease
- (2014) Ioannis Ugo Isaias et al. Frontiers in Aging Neuroscience
- Gender differences in quality of life following subthalamic stimulation for Parkinson's disease
- (2013) G.-M. Hariz et al. ACTA NEUROLOGICA SCANDINAVICA
- The Free Radical Theory of Aging Is Dead. Long Live the Damage Theory!
- (2013) Vadim N. Gladyshev ANTIOXIDANTS & REDOX SIGNALING
- ?7 Nicotinic Acetylcholine Receptor Mediated Neuroprotection in Parkinson's Disease
- (2013) Jun Kawamata et al. CURRENT DRUG TARGETS
- Nicotine-encapsulated poly(lactic-co-glycolic) acid nanoparticles improve neuroprotective efficacy against MPTP-induced parkinsonism
- (2013) Manindra Nath Tiwari et al. FREE RADICAL BIOLOGY AND MEDICINE
- Parkinson disease: from pathology to molecular disease mechanisms
- (2013) David T. Dexter et al. FREE RADICAL BIOLOGY AND MEDICINE
- α-Synuclein Oligomers Impair Neuronal Microtubule-Kinesin Interplay
- (2013) Iryna Prots et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in Parkinson’s disease
- (2013) G Drui et al. MOLECULAR PSYCHIATRY
- Comparison of Fetal Mesencephalic Grafts, AAV-delivered GDNF, and Both Combined in an MPTP-induced Nonhuman Primate Parkinson’s Model
- (2013) D Eugene Redmond et al. MOLECULAR THERAPY
- Parkinson's Disease Gene Therapy: Success by Design Meets Failure by Efficacy
- (2013) Raymond T Bartus et al. MOLECULAR THERAPY
- Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease
- (2013) Laura Dunn et al. NEUROBIOLOGY OF AGING
- Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients
- (2013) R. T. Bartus et al. NEUROLOGY
- Pathogenesis-Targeted, Disease-Modifying Therapies in Parkinson Disease
- (2013) Amaal AlDakheel et al. Neurotherapeutics
- Distribution and compartmental organization of GABAergic medium-sized spiny neurons in the mouse nucleus accumbens
- (2013) Giuseppe Gangarossa et al. Frontiers in Neural Circuits
- Genetics of Parkinson's Disease
- (2013) C. Klein et al. Cold Spring Harbor Perspectives in Medicine
- Dopamine, Reward, and Frontostriatal Circuitry in Impulse Control Disorders in Parkinson's Disease: Insights from Functional Imaging
- (2012) Nicola Ray et al. CLINICAL EEG AND NEUROSCIENCE
- Cotinine: A Potential New Therapeutic Agent against Alzheimer's disease
- (2012) Valentina Echeverria et al. CNS Neuroscience & Therapeutics
- Psychostimulant effect of levodopa: reversing sensitisation is possible
- (2012) Anna Castrioto et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases
- (2012) Rajnish K. Chaturvedi et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Evolution of Dopamine Receptor Genes of the D1 Class in Vertebrates
- (2012) Kei Yamamoto et al. MOLECULAR BIOLOGY AND EVOLUTION
- Caffeine for treatment of Parkinson disease: A randomized controlled trial
- (2012) R. B. Postuma et al. NEUROLOGY
- Non-Motor Symptoms in Patients with Parkinson’s Disease – Correlations with Inflammatory Cytokines in Serum
- (2012) Daniel Lindqvist et al. PLoS One
- The basal ganglia: motor and cognitive relationships in a clinical neurobehavioral context
- (2012) Gerry Leisman et al. REVIEWS IN THE NEUROSCIENCES
- Striatal microcircuitry and movement disorders
- (2012) Aryn H. Gittis et al. TRENDS IN NEUROSCIENCES
- Cotinine: Beyond that Expected, More than a Biomarker of Tobacco Consumption
- (2012) Valentina Echeverria Moran Frontiers in Pharmacology
- Modulation of Striatal Projection Systems by Dopamine
- (2011) Charles R. Gerfen et al. Annual Review of Neuroscience
- Single-Cell Redox Imaging Demonstrates a Distinctive Response of Dopaminergic Neurons to Oxidative Insults
- (2011) Maxx P. Horowitz et al. ANTIOXIDANTS & REDOX SIGNALING
- Impulse control disorders in Parkinsonʼs disease
- (2011) Valerie Voon et al. CURRENT OPINION IN NEUROLOGY
- Epidemiology and etiology of Parkinson’s disease: a review of the evidence
- (2011) Karin Wirdefeldt et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Stress, depression and Parkinson's disease
- (2011) Ann M. Hemmerle et al. EXPERIMENTAL NEUROLOGY
- Neuroprotection of midbrain dopamine neurons by nicotine is gated by cytoplasmic Ca2+
- (2011) Damien Toulorge et al. FASEB JOURNAL
- α-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseases
- (2011) Zane S. Martin et al. JOURNAL OF NEUROCHEMISTRY
- AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial
- (2011) Peter A LeWitt et al. LANCET NEUROLOGY
- Interventional MRI-guided Putaminal Delivery of AAV2-GDNF for a Planned Clinical Trial in Parkinson's Disease
- (2011) R Mark Richardson et al. MOLECULAR THERAPY
- Etiology and pathogenesis of Parkinson's disease
- (2011) Anthony H. Schapira et al. MOVEMENT DISORDERS
- GABAergic circuits mediate the reinforcement-related signals of striatal cholinergic interneurons
- (2011) Daniel F English et al. NATURE NEUROSCIENCE
- Increased Oxidative Damage and Decreased Antioxidant Function in Aging Human Substantia Nigra Compared to Striatum: Implications for Parkinson’s Disease
- (2011) C. Venkateshappa et al. NEUROCHEMICAL RESEARCH
- 6 2* and 4 2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson's Disease
- (2011) M. Quik et al. PHARMACOLOGICAL REVIEWS
- The Evolution of Dopamine Systems in Chordates
- (2011) Kei Yamamoto et al. Frontiers in Neuroanatomy
- Clinical progression in Parkinson disease and the neurobiology of axons
- (2010) Hsiao-Chun Cheng et al. ANNALS OF NEUROLOGY
- The cholinergic system and Parkinson disease
- (2010) Nicolaas I. Bohnen et al. BEHAVIOURAL BRAIN RESEARCH
- Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial
- (2010) William J Marks et al. LANCET NEUROLOGY
- Basal ganglia physiology and deep brain stimulation
- (2010) Andres M. Lozano et al. MOVEMENT DISORDERS
- Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease
- (2010) Elena Moro et al. MOVEMENT DISORDERS
- A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease
- (2010) Barry J. Snow et al. MOVEMENT DISORDERS
- Maladie de Parkinson : de la physiopathologie des troubles psychiques à la maîtrise du traitement dopaminergique
- (2010) S. Thobois et al. REVUE NEUROLOGIQUE
- Nicotine is a Selective Pharmacological Chaperone of Acetylcholine Receptor Number and Stoichiometry. Implications for Drug Discovery
- (2009) Henry A. Lester et al. AAPS Journal
- Reduced α4β2*–Nicotinic Acetylcholine Receptor Binding and Its Relationship to Mild Cognitive and Depressive Symptoms in Parkinson Disease
- (2009) Philipp M. Meyer et al. ARCHIVES OF GENERAL PSYCHIATRY
- Nicotinic Receptor-Mediated Neuroprotection in Neurodegenerative Disease Models
- (2009) Shun Shimohama BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Functional Effects of AAV2-GDNF on the Dopaminergic Nigrostriatal Pathway in Parkinsonian Rhesus Monkeys
- (2009) Jamie L. Eberling et al. HUMAN GENE THERAPY
- Safety Evaluation of AAV2-GDNF Gene Transfer into the Dopaminergic Nigrostriatal Pathway in Aged and Parkinsonian Rhesus Monkeys
- (2009) Xiaomin Su et al. HUMAN GENE THERAPY
- Decrease of Nicotinic Receptors in the Nigrostriatal System in Parkinson's Disease
- (2009) Aurélie Kas et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Neuronal cell replacement in Parkinson’s disease
- (2009) E. Hedlund et al. JOURNAL OF INTERNAL MEDICINE
- Nicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys
- (2009) Luping Z. Huang et al. JOURNAL OF NEUROCHEMISTRY
- Parkinson's disease
- (2009) Andrew J Lees et al. LANCET
- Effect of Genome Size on AAV Vector Packaging
- (2009) Zhijian Wu et al. MOLECULAR THERAPY
- Neuroinflammation in the living brain of Parkinson's disease
- (2009) Yasuomi Ouchi et al. PARKINSONISM & RELATED DISORDERS
- Striatal Medium-Sized Spiny Neurons: Identification by Nuclear Staining and Study of Neuronal Subpopulations in BAC Transgenic Mice
- (2009) Miriam Matamales et al. PLoS One
- Are adenosine antagonists, such as istradefylline, caffeine, and chocolate, useful in the treatment of Parkinson's disease?
- (2008) Joseph Jankovic ANNALS OF NEUROLOGY
- Cotinine-induced convergence of the cholinergic and PI3 kinase-dependent anti-inflammatory pathways in innate immune cells
- (2008) Kunal Rehani et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Smoking and Parkinson's disease: Does nicotine affect α-synuclein fibrillation?
- (2008) Dong-Pyo Hong et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Applications of Lentiviral Vectors for Biology and Gene Therapy of Neurological Disorders
- (2008) Cecilia Lundberg et al. CURRENT GENE THERAPY
- Mitochondrial Import and Accumulation of α-Synuclein Impair Complex I in Human Dopaminergic Neuronal Cultures and Parkinson Disease Brain
- (2008) Latha Devi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Deep brain stimulation for parkinsonian gait disorders
- (2008) Andres M. Lozano et al. JOURNAL OF NEUROLOGY
- Mesolimbic Functional Magnetic Resonance Imaging Activations during Reward Anticipation Correlate with Reward-Related Ventral Striatal Dopamine Release
- (2008) B. H. Schott et al. JOURNAL OF NEUROSCIENCE
- Cotinine Selectively Activates a Subpopulation of 3/ 6 2 Nicotinic Receptors in Monkey Striatum
- (2008) K. O'Leary et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Continuous and Intermittent Nicotine Treatment Reduces L-3,4-Dihydroxyphenylalanine (L-DOPA)-Induced Dyskinesias in a Rat Model of Parkinson's Disease
- (2008) T. Bordia et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Adeno-Associated Virus Vector Genomes Persist as Episomal Chromatin in Primate Muscle
- (2008) M. Penaud-Budloo et al. JOURNAL OF VIROLOGY
- Levodopa-related motor complications-Phenomenology
- (2008) Susan H. Fox et al. MOVEMENT DISORDERS
- Results from a phase I safety trial of hAADC gene therapy for Parkinson disease
- (2008) J. L. Eberling et al. NEUROLOGY
- Deep brain stimulation for Parkinson’s disease
- (2008) Patricia Limousin et al. Neurotherapeutics
- Cigarette smoke, nicotine and cotinine protect against 6-hydroxydopamine-induced toxicity in SH-SY5Y cells
- (2008) Karen Riveles et al. NEUROTOXICOLOGY
- Smoking and tea consumption delay onset of Parkinson's disease
- (2008) Boris Kandinov et al. PARKINSONISM & RELATED DISORDERS
- Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer's and Parkinson's disease
- (2007) Marina et al. Frontiers in Bioscience-Landmark
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started